» Articles » PMID: 1883322

Substrate-specificity of Glutamine Transporters in Membrane Vesicles from Rat Liver and Skeletal Muscle Investigated Using Amino Acid Analogues

Overview
Journal Biochem J
Specialty Biochemistry
Date 1991 Aug 15
PMID 1883322
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

We investigated the effects of glutamine and histidine analogues on glutamine transport processes in membrane vesicles prepared from rat liver (sinusoidal membrane) and skeletal muscle (sarcolemma). L-[14C]Glutamine is transported in these membranes predominantly by Systems N/Nm (liver and muscle respectively), and to a lesser extent by Systems A and L (e.g. about 60, 20 and 20% of total flux respectively via Systems N, A and L at 0.05 mM-glutamine in liver membrane vesicles). The glutamine anti-metabolites 6-diazo-5-oxo-L-norleucine and acivicin were relatively poor inhibitors of glutamine uptake into liver membrane vesicles (less than 25% inhibition at 20-fold excess) and appeared primarily to inhibit System A activity (i.e. N-methylaminoisobutyric acid-inhibitable glutamine uptake). In similar experiments azaserine (also a glutamine anti-metabolite) inhibited approx. 50% of glutamine uptake, apparently by inhibition of System A and also of System L (i.e. 2-amino-2-carboxybicyclo[2,2,1]heptane-inhibitable glutamine uptake). Glutamate gamma-hydroxamate, aspartate beta-hydroxamate, histidine and N'-methylhistidine were all strong inhibitors of glutamine uptake into liver membrane vesicles (greater than 65% inhibition at 20-fold excess), but neither homoglutamine nor N'-methylhistidine produced inhibition. L-Glutamate-gamma-hydroxamate was shown to be a competitive inhibitor of glutamine transport via System N (Ki approximately 0.6 mM). Glutamine uptake in sarcolemmal vesicles showed a similar general pattern of inhibition as in liver membrane vesicles. The results highlight limits on the substrate tolerance of System N; we suggest that the presence of both an L-alpha-amino acid group and a nitrogen group with a delocalized lone-pair of electrons (amide or pyrrole type), separated by a specific intramolecular distance (C2-C4 chain equivalent), is important for substrate recognition by this transporter.

Citing Articles

O-GlcNAcylation: a pro-survival response to acute stress in the cardiovascular and central nervous systems.

Xue Q, Ji S, Xu H, Yu S Eur J Med Res. 2024; 29(1):174.

PMID: 38491477 PMC: 10943874. DOI: 10.1186/s40001-024-01773-z.


Increased/Targeted Brain (Pro)Drug Delivery via Utilization of Solute Carriers (SLCs).

Huttunen J, Adla S, Markowicz-Piasecka M, Huttunen K Pharmaceutics. 2022; 14(6).

PMID: 35745806 PMC: 9228667. DOI: 10.3390/pharmaceutics14061234.


ALL blasts drive primary mesenchymal stromal cells to increase asparagine availability during asparaginase treatment.

Chiu M, Taurino G, Dander E, Bardelli D, Fallati A, Andreoli R Blood Adv. 2021; 5(23):5164-5178.

PMID: 34614505 PMC: 9153005. DOI: 10.1182/bloodadvances.2020004041.


A Time-Course Comparison of Skeletal Muscle Metabolomic Alterations in Walker-256 Tumour-Bearing Rats at Different Stages of Life.

de Matuoka E Chiocchetti G, Lopes-Aguiar L, Angelo da Silva Miyaguti N, Viana L, De Moraes Salgado C, Orvoen O Metabolites. 2021; 11(6).

PMID: 34202988 PMC: 8234487. DOI: 10.3390/metabo11060404.


SLC6A14 and SLC38A5 Drive the Glutaminolysis and Serine-Glycine-One-Carbon Pathways in Cancer.

Sniegowski T, Korac K, Bhutia Y, Ganapathy V Pharmaceuticals (Basel). 2021; 14(3).

PMID: 33806675 PMC: 8000594. DOI: 10.3390/ph14030216.


References
1.
Huber K, Rosenfeld H, Roberts J . Uptake of glutamine antimetabolites 6-diazo-5-oxo-L-norleucine (DON) and acivicin in sensitive and resistant tumor cell lines. Int J Cancer. 1988; 41(5):752-5. DOI: 10.1002/ijc.2910410519. View

2.
Wisher M, Evans W . Functional polarity of the rat hepatocyte surface membrane. Isolation and characterization of plasma-membrane subfractions from the blood-sinusoidal, bile-Canalicular and contiguous surfaces of the hepatocyte. Biochem J. 1975; 146(2):375-88. PMC: 1165315. DOI: 10.1042/bj1460375. View

3.
Prajda N . Enzyme targets of antiglutamine agents in cancer chemotherapy. Adv Enzyme Regul. 1985; 24:207-23. DOI: 10.1016/0065-2571(85)90077-9. View

4.
CHRISTENSEN H . Distinguishing amino acid transport systems of a given cell or tissue. Methods Enzymol. 1989; 173:576-616. DOI: 10.1016/s0076-6879(89)73040-8. View

5.
Abumrad N, Williams P, Geer R, Flakoll P, Cersosimo E, Brown L . Inter-organ metabolism of amino acids in vivo. Diabetes Metab Rev. 1989; 5(3):213-26. DOI: 10.1002/dmr.5610050302. View